Trial Site Detail

 

Drug:
Nilotinib or Imatinib
Trial:
Nilotinib 800 Mg And Imatinib 800 Mg For The Treatment Of Patients With Gastrointestinal Stromal Tumors (Gist) Refractory To Imatinib 400 Mg (LANGIST)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Terminated

 

QE II Health Sciences Center

     
Halifax , NS
Canada

 

Principal Investigator:
Contact:
Activation Status of this Site:
Closed
Notes about this Site:
QE II Health Sciences Center Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.